Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

[Research development of novel antineoplastic agents].

Wada T, Matsui H.

Nihon Yakurigaku Zasshi. 2013 Oct;142(4):149. Japanese. No abstract available.

PMID:
24369542
2.

[Challenges and prospects for drug development of molecular targeting agents in Japan].

Iwasaki M.

Nihon Rinsho. 2012 Nov;70 Suppl 8:695-702. Japanese. No abstract available.

PMID:
23513923
3.

[Research strategy for development of antineoplastic agents].

Funahash Y.

Nihon Yakurigaku Zasshi. 2013 Jan;141(1):3. Japanese. No abstract available.

PMID:
23967518
4.

Anticancer drug development from traditional cytotoxic to targeted therapies: evidence of shorter drug research and development time, and shorter drug lag in Japan.

Kawabata-Shoda E, Masuda S, Kimura H.

J Clin Pharm Ther. 2012 Oct;37(5):547-52. doi: 10.1111/j.1365-2710.2012.01332.x. Epub 2012 Mar 20.

PMID:
22428857
5.

[Drug discovery sciences in Japan with focus on molecular-targeted drugs].

Furukawa K, Hamamura K, Ohkawa Y, Furukawa K.

Nihon Rinsho. 2010 Oct;68(10):1797-802. Review. Japanese.

PMID:
20954320
6.

[Translational research - towards personalized medicine].

Tokui T.

Nihon Yakurigaku Zasshi. 2013 Mar;141(3):122-5. Review. Japanese. No abstract available.

PMID:
23470475
7.

"Discovery and development of new anticancer drugs inspired from natural product leads" part 2.

Rane R, Karpoormath R.

Anticancer Agents Med Chem. 2015;15(8):932. No abstract available.

PMID:
26289951
8.

Are current development programs realising the full potential of new agents?

L√łnning PE.

Breast Cancer Res. 2010 Dec 20;12 Suppl 4:S23. doi: 10.1186/bcr2752. No abstract available.

9.

Developing drugs for pediatric malignancies.

Adamson PC.

Clin Adv Hematol Oncol. 2013 Apr;11(4):227-9. No abstract available.

PMID:
23604239
10.

Anticancer drug development: moving away from the old habits.

Ades F, Zardavas D, Aftimos P, Awada A.

Curr Opin Oncol. 2014 May;26(3):334-9. doi: 10.1097/CCO.0000000000000076. No abstract available.

PMID:
24614094
11.

Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target.

Plummer R.

Clin Cancer Res. 2010 Sep 15;16(18):4527-31. doi: 10.1158/1078-0432.CCR-10-0984. Epub 2010 Sep 7. Review.

12.

[Present status and perspective of targeted therapy for B-cell lymphoma].

Ohmachi K.

Rinsho Ketsueki. 2011 Aug;52(8):609-17. Review. Japanese. No abstract available.

PMID:
21897066
13.

Deciding priorities in Pharma.

Koehler M.

Breast Cancer Res. 2010 Dec 20;12 Suppl 4:S21. doi: 10.1186/bcr2750. No abstract available.

14.

(Part I) Recent trends in anti-cancer drug discovery.

Sarkar FH.

Mini Rev Med Chem. 2010 May;10(5):357-8. No abstract available.

PMID:
20482491
15.

Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.

Wong MS, Sidik SM, Mahmud R, Stanslas J.

Clin Exp Pharmacol Physiol. 2013 May;40(5):307-19. doi: 10.1111/1440-1681.12083. Review.

PMID:
23534409
16.

Anticancer drug discovery in the future: an evolutionary perspective.

Ma X, Wang Z.

Drug Discov Today. 2009 Dec;14(23-24):1136-42. doi: 10.1016/j.drudis.2009.09.006. Epub 2009 Oct 1. Review.

PMID:
19800414
17.

[Future directions of anticancer drug development in Japan].

Akaza H, Kawai K, Tsuruo T, Tsukagoshi S, Aiba K, Shimada Y, Kakeji Y, Ishikawa H, Ikeda T, Nakamura S, Tamura T, Yamamoto N, Isonishi S, Hinotsu S, Hirose M, Katsura J.

Gan To Kagaku Ryoho. 2008 Feb;35(2):351-60. Japanese.

PMID:
18281781
18.

Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery.

Seo SY.

Arch Pharm Res. 2012 Feb;35(2):197-200. doi: 10.1007/s12272-012-0221-9.

PMID:
22370774
19.

Promising targets and drugs in development for colorectal cancer.

Thompson C, Leong S, Messersmith W.

Semin Oncol. 2011 Aug;38(4):588-97. doi: 10.1053/j.seminoncol.2011.05.013. Review.

PMID:
21810518
20.

[Past and current problems in tumor research].

von Wasielewski E, Sedlacek HH.

Dtsch Med Wochenschr. 1986 Apr 18;111(16):630-7. German. No abstract available.

PMID:
3956405

Supplemental Content

Support Center